Home Aerie Pharmaceuticals

Aerie Pharmaceuticals

acquired
IPO Delisting
Ophthalmic Disease Treatment Drug Developer
Basic
Enterprise Profile

Basic Information

Aerie Pharmaceuticals, Inc. is a biotechnology company engaged in the discovery, development, and commercialization of pharmaceuticals for the treatment of ophthalmic diseases. It focuses on developing products for the pharmaceutical treatment of glaucoma. The medicinal chemists, biologists, engineers, and clinical researchers at Aerie Pharmaceuticals concentrate on the research and development of small molecule drugs and formulations.
Aerie Pharmaceuticals, Inc.
NorthCarolina,United States of America
101~500 people
January 01, 2005
info@aeriepharma.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations
Concept
Ophthalmology Ocular Diseases Therapeutic Products
Application Scenarios
Chemical Drug Innovative Drugs